Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Micronutrient intake in children with cystic fibrosis in Sydney, Australia

  • Read more about Micronutrient intake in children with cystic fibrosis in Sydney, Australia

The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease

  • Read more about The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease

Randomized Controlled Study of Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Hospitalized Patients with Pulmonary Exacerbation of Cystic Fibrosis

  • Read more about Randomized Controlled Study of Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Hospitalized Patients with Pulmonary Exacerbation of Cystic Fibrosis

Oxidative Stress and Abnormal Bioactive Lipids in Early Cystic Fibrosis Lung Disease.

  • Read more about Oxidative Stress and Abnormal Bioactive Lipids in Early Cystic Fibrosis Lung Disease.

Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

  • Read more about Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Ventilation and perfusion assessed by functional MRI in children with CF: reproducibility in comparison to lung function

  • Read more about Ventilation and perfusion assessed by functional MRI in children with CF: reproducibility in comparison to lung function

Addressing the Burden of Illness in Adults with Cystic Fibrosis with Screening and Triage: An Early Intervention Model of Palliative Care

  • Read more about Addressing the Burden of Illness in Adults with Cystic Fibrosis with Screening and Triage: An Early Intervention Model of Palliative Care

An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

  • Read more about An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines

  • Read more about Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines

High airborne level of Aspergillus fumigatus and presence of azole-resistant TR34/L98H isolates in the home of a cystic fibrosis patient harbouring chronic colonisation with azole-resistant H285Y A. fumigatus.

  • Read more about High airborne level of Aspergillus fumigatus and presence of azole-resistant TR34/L98H isolates in the home of a cystic fibrosis patient harbouring chronic colonisation with azole-resistant H285Y A. fumigatus.
  • first
  • previous
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)